Search research articles
Contact Us
Filters
Showing results (481-490 of 654) with videos related to
Page
of 66
Sort By:
Cancer Research
|
May 25, 2019
Differential Activity of ATR and WEE1 Inhibitors in a Highly Sensitive Subpopulation of DLBCL Linked to Replication Stress
Lucy A Young, Lenka Oplustil O'Connor, Christelle de Renty, et al.
Annals of Surgery
|
November 20, 2020
Survival After Trimodality Therapy in Patients With Locally Advanced Esophagogastric Adenocarcinoma: Does Only a Complete Pathologic Response Matter?
Smita Sihag, Tamar Nobel, Meier Hsu, et al.
Annals of Surgery
|
June 6, 2024
Genomic Landscape of Adenocarcinomas Across the Gastroesophageal Junction: Moving on From the Siewert Classification
Masaya Nakauchi, Henry S Walch, Samuel Nussenzweig, et al.
The Annals of Thoracic Surgery
|
September 4, 2020
Thoracic Metastasectomy in Germ Cell Tumor Patients Treated With First-line Versus Salvage Therapy
Raul Caso, Gregory D Jones, Kay See Tan, et al.
Cancers
|
April 30, 2021
Management of Synchronous Extrathoracic Oligometastatic Non-Small Cell Lung Cancer
Gregory D Jones, Harry B Lengel, Meier Hsu, et al.
JAMA Network Open
|
January 5, 2023
Analysis of Tumor Mutational Burden, Progression-Free Survival, and Local-Regional Control in Patents with Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and Durvalumab
Emily S Lebow, Annemarie Shepherd, Jordan E Eichholz, et al.
Molecular Cancer Therapeutics
|
August 28, 2020
Phase I, Pharmacogenomic, Drug Interaction Study of Sorafenib and Bevacizumab in Combination with Paclitaxel in Patients with Advanced Refractory Solid Tumors
E Gabriela Chiorean, Susan M Perkins, R Matthew Strother, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
July 20, 2023
Lobectomy, segmentectomy, or wedge resection for peripheral clinical T1aN0 non-small cell lung cancer: A post hoc analysis of CALGB 140503 (Alliance)
Nasser Altorki, Xiaofei Wang, Bryce Damman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 14, 2025
Erratum: Paclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease
Jack P Gleeson, Andrea Knezevic, Maria Bromberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 19, 2024
Paclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease
Jack P Gleeson, Andrea Knezevic, Maria Bromberg, et al.
Page
of 66
Search research articles
Search
Showing results (481-490 of 654) with videos related to
Sort By:
Page
of 66
Cancer Research
|
May 25, 2019
Differential Activity of ATR and WEE1 Inhibitors in a Highly Sensitive Subpopulation of DLBCL Linked to Replication Stress
Lucy A Young, Lenka Oplustil O'Connor, Christelle de Renty, et al.
Annals of Surgery
|
November 20, 2020
Survival After Trimodality Therapy in Patients With Locally Advanced Esophagogastric Adenocarcinoma: Does Only a Complete Pathologic Response Matter?
Smita Sihag, Tamar Nobel, Meier Hsu, et al.
Annals of Surgery
|
June 6, 2024
Genomic Landscape of Adenocarcinomas Across the Gastroesophageal Junction: Moving on From the Siewert Classification
Masaya Nakauchi, Henry S Walch, Samuel Nussenzweig, et al.
The Annals of Thoracic Surgery
|
September 4, 2020
Thoracic Metastasectomy in Germ Cell Tumor Patients Treated With First-line Versus Salvage Therapy
Raul Caso, Gregory D Jones, Kay See Tan, et al.
Cancers
|
April 30, 2021
Management of Synchronous Extrathoracic Oligometastatic Non-Small Cell Lung Cancer
Gregory D Jones, Harry B Lengel, Meier Hsu, et al.
JAMA Network Open
|
January 5, 2023
Analysis of Tumor Mutational Burden, Progression-Free Survival, and Local-Regional Control in Patents with Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and Durvalumab
Emily S Lebow, Annemarie Shepherd, Jordan E Eichholz, et al.
Molecular Cancer Therapeutics
|
August 28, 2020
Phase I, Pharmacogenomic, Drug Interaction Study of Sorafenib and Bevacizumab in Combination with Paclitaxel in Patients with Advanced Refractory Solid Tumors
E Gabriela Chiorean, Susan M Perkins, R Matthew Strother, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
July 20, 2023
Lobectomy, segmentectomy, or wedge resection for peripheral clinical T1aN0 non-small cell lung cancer: A post hoc analysis of CALGB 140503 (Alliance)
Nasser Altorki, Xiaofei Wang, Bryce Damman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 14, 2025
Erratum: Paclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease
Jack P Gleeson, Andrea Knezevic, Maria Bromberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 19, 2024
Paclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease
Jack P Gleeson, Andrea Knezevic, Maria Bromberg, et al.
Page
of 66